Luis Humberto Anaya-Velarde, MD, MSc

Director, Medical Safety Officer
Johnson & Johnson Innovative Medicine
Tienen, Belgium

Disclosure information not submitted.

Presentation(s):

• Ad26.COV2.S vaccine and thromboembolic risks among premenopausal women: Exploring variation by combined hormonal medication use

  Monday, August 26, 2024
  5:30 PM – 5:45 PM CEST